Reuters logo
Drugmaker Regeneron's quarterly profit surges 47 pct
2017年11月8日 / 中午11点40分 / 12 天前

Drugmaker Regeneron's quarterly profit surges 47 pct

Nov 8 (Reuters) - Regeneron Pharmaceuticals Inc reported a 47 percent jump in quarterly profit on Wednesday on higher demand for its flagship eye treatment Eylea.

The U.S. biotechnology company said net income rose to $388.3 million, or $3.32 per share, in the third quarter ended Sept. 30 from $264.8 million, or $2.27 per share, a year earlier.

Total revenue rose to $1.50 billion from $1.22 billion. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Sriraj Kalluvila)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below